{"nct_id":"NCT06461897","title":"A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-08-19","start_date_type":"ACTUAL","primary_completion_date":"2030-07","primary_completion_date_type":"ESTIMATED","completion_date":"2030-07","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["ABBV"]}